Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy

被引：0
|
作者：
Chen, Wenwen [1 ]
Bhatia, Shailender [1 ]
Brohl, Andrew S. [2 ]
Chandra, Sunandana [3 ]
Dakhil, Sumia [1 ]
Fecher, Leslie A. [4 ]
Gao, Ling [5 ]
Gooley, Ted A. [6 ]
Hanna, Glenn J. [7 ]
Hibbert, Reina
Kelly, Ciara M. [8 ]
Kiriluk, Samantha M.
Lewis, Karl [9 ]
Moschos, Stergios [10 ]
Nghiem, Paul [11 ]
Thompson, John A. [1 ]
Tykodi, Scott S. [1 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Moffit Canc Ctr, Tampa, FL USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[4] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA USA
[7] Dana Farber Canc Inst, Boston, MA USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Univ Colorado Canc Ctr, Anschutz Med Campus, Aurora, CO USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[11] Univ Washington, Div Dermatol, Seattle, WA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：2837 / 2837
页数：1
相关论文
共 50 条
  • [1] Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapy
    Bhakuni, R.
    Goff, P.
    Lee, J. H.
    Pulliam, T.
    Tabachnick-Cherny, S.
    Morningstar, C. D.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S147 - S147
  • [2] Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It
    Zielinska, Magdalena K.
    Ciazynska, Magdalena
    Sulejczak, Dorota
    Rutkowski, Piotr
    Czarnecka, Anna M.
    BIOMOLECULES, 2025, 15 (02)
  • [3] Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapy
    Yi-Yu Wang
    Jin-Fei Lin
    Wen-Wei Wu
    Zhe Fu
    Fen Cao
    Yan-Xing Chen
    Hai-Yu Mo
    Hui Sheng
    Ze-Xian Liu
    Zhao-Lei Zeng
    Xin-Yuan Guan
    Huai-Qiang Ju
    Kun Liao
    Rui-Hua Xu
    Nature Communications, 16 (1)
  • [4] Therapy of the metastatic Merkel Cell Carcinoma with the Anti-PD-1 Antibody Pembrolizumab
    Meier, K.
    Wilhelmi, J.
    Lomberg, D.
    Spaenkuch, I
    Scheu, A.
    Leiter, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 171 - 171
  • [5] Inhibition of PCSK9: A Promising Enhancer for Anti-PD-1/PD-L1 Immunotherapy
    Sun, Shengbo
    Ma, Jingxin
    Zuo, Tingting
    Shi, Jinyao
    Sun, Liting
    Meng, Cong
    Shu, Wenlong
    Yang, Zhengyang
    Yao, Hongwei
    Zhang, Zhongtao
    RESEARCH, 2024, 7
  • [6] T Cell-Signaling-Responsive Conjugate of Antibody with siRNA to Overcome Acquired Resistance to anti-PD-1 Immunotherapy
    Wang, Xingxing
    Wang, Yan
    Li, Ji
    Tian, Tian
    Li, Jinbo
    Guo, Zijian
    Zhang, Yan
    ADVANCED THERAPEUTICS, 2022, 5 (01)
  • [7] Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?
    Balachander, Kannan
    Paramasivam, Arumugam
    ORAL ONCOLOGY, 2022, 132
  • [8] Anti-PD-1 Immunotherapy Potentiates the Radiation-Induced Lung Injury
    Xue, J.
    Du, S.
    Dicker, A. P.
    Lu, Y.
    Lu, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S205 - S205
  • [9] Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
    Miller, Natalie J.
    Church, Candice D.
    Fling, Steven P.
    Kulikauskas, Rima
    Ramchurren, Nirasha
    Shinohara, Michi M.
    Kluger, Harriet M.
    Bhatia, Shailender
    Lundgren, Lisa
    Cheever, Martin A.
    Topalian, Suzanne L.
    Nghiem, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [10] Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas
    Mantripragada, Kalyan
    Birnbaum, Ariel
    CUREUS, 2015, 7 (12):
12345